Novel 'bio-inspired' environments for testing novel surgical technologies - paving the way

Loading

Novel 'bio-inspired' environments for testing novel surgical technologies - paving the way

10 Nov 2021
Theatre 3
Disruptive Technology

Introducing a surgical innovation is necessarily challenging, requiring a complex pathway of device regulation and translational clinical trials to confirm safety and efficacy. However, to ensure adoption and uptake, a critical component of a device's pathway to market is engagement with surgeon stakeholders, and where possible, co-development. Achieving an integrated approach to this can prove challenging, particularly in the context of pre-clinical testing.

We discuss and explore the use of emerging technologies which provide alternate, 'tissue sparing' interfaces for testing surgical tools and technologies. Case studies will be discussed in the context of virtual reality and mixed reality environments as well as advanced cell cultures and 3D bioprinting. Applying 'bio-inspired' engineering simulation throughout development and the regulatory approval process promotes innovation, while reducing costs, shortening time to market and meeting safety standards and product deadlines.

Speakers
Timothy Constandinou, Deputy Director, Centre for Bio-inspired Technology - Imperial College London
Jinendra Ekanayake, Post CCT Senior Neurosurgical Fellow - Royal Sussex University Hospital/VRIMS
  • “Future Surgery 2021 will be the first of its kind in the UK, drawing on the work our Commission on the Future of Surgery has done to predict the transformation in the medical care for millions of patients.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • “Driven by changes in digital technologies and our fast-evolving understanding of genomics, innovations are expected to affect how we undertake surgery, and how we train surgeons in future.”
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "Alongside the conference organisers, CloserStill, we aim to deliver a high-quality event that will provide both professional development and discussion space for surgeons and their teams."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England
  • "We look forward to welcoming colleagues to what promises to be a very high-quality programme and an exciting two days of thought-provoking training and engagement with medical suppliers."
    Andrew Reed, Chief Executive of the Royal College of Surgeons of England

EVENT PARTNER


 

PLATINUM SPONSOR

Edinurgh

PLATINUM SPONSOR

CMR

PLATINUM SPONSOR

quilter

GOLD SPONSOR


 

GOLD SPONSOR


 

GOLD SPONSOR

Sony

Sustainability Sponsor

SPONSOR

AneticAid

SPONSOR


 

SPONSOR


 

SPONSOR

Creed Medical

SPONSOR

Corza Medical

SPONSOR


 

SPONSOR

Epiqar

SPONSOR

Fundamental Surgery

SPONSOR


 

SPONSOR

Intuitive

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR


 

SPONSOR

  • Open Medical

 

SPONSOR

  • 365 Healthcare

 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

British Orthopaedic Association

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter


 

Event Supporter

SSSIM

MEDIA PARTNER

CSJ

MEDIA PARTNER

Operating Theatre Journal